Table 4.
Characteristics | OS | BCSS | |||||||
---|---|---|---|---|---|---|---|---|---|
95% CI | 95% CI | ||||||||
HR | Low | High | P | HR | Low | High | P | ||
Race | |||||||||
White | Reference | Reference | |||||||
Black | 1.381 | 1.207 | 1.58 | <0.001 | 1.33 | 1.093 | 1.618 | 0.004 | |
Other | 0.683 | 0.561 | 0.833 | <0.001 | 0.719 | 0.535 | 0.966 | 0.028 | |
Age | |||||||||
<50 | Reference | Reference | |||||||
50≤;<70 | 2.032 | 1.675 | 2.464 | <0.001 | 1.443 | 1.13 | 1.842 | 0.003 | |
≥70 | 5.251 | 4.338 | 6.357 | <0.001 | 3.443 | 2.693 | 4.401 | <0.001 | |
Grade | |||||||||
I | Reference | Reference | |||||||
II | 1.185 | 1.004 | 1.397 | 0.045 | 1.766 | 1.215 | 2.565 | 0.003 | |
III | 1.557 | 1.294 | 1.875 | <0.001 | 2.666 | 1.814 | 3.919 | <0.001 | |
Subtype | |||||||||
HR+/Her2- | Reference | Reference | |||||||
HR+/Her2+ | 1.326 | 1.105 | 1.592 | 0.002 | 0.987 | 0.729 | 1.337 | 0.933 | |
HR-/Her2+ | 1.365 | 1.089 | 1.712 | 0.007 | 1.107 | 0.797 | 1.538 | 0.544 | |
HR-/Her2- | 1.555 | 1.345 | 1.799 | <0.001 | 1.544 | 1.269 | 1.88 | <0.001 | |
Stage | |||||||||
I | Reference | Reference | |||||||
II | 2.48 | 2.145 | 2.868 | <0.001 | 4.729 | 3.687 | 6.066 | <0.001 | |
III | 6.789 | 5.894 | 7.819 | <0.001 | 18.161 | 14.376 | 22.942 | <0.001 | |
Radiation | |||||||||
No | Reference | Reference | |||||||
Yes | 0.199 | 0.175 | 0.225 | <0.001 | 0.191 | 0.158 | 0.231 | <0.001 | |
Chemotherapy | |||||||||
No | Reference | Reference | |||||||
Yes | 0.772 | 0.678 | 0.879 | <0.001 | 0.943 | 0.78 | 1.141 | 0.546 | |
Year of diagnosis | |||||||||
2020 | Reference | Reference | |||||||
2018 | 0.842 | 0.723 | 0.981 | 0.027 | 0.945 | 0.74 | 1.208 | 0.652 | |
2019 | 0.912 | 0.786 | 1.06 | 0.231 | 1.055 | 0.83 | 1.341 | 0.663 |